Bangladesh’s pharmaceutical exports posted steady growth in the first eight months of the current fiscal year, buoyed by ...

“Pharma continues turning to AI to better understand diseases and speed up drug discovery and development,” said Noam Solomon ...

Investing in dividend stocks can be a great strategy, especially if you pick solid companies that pay reliable and high-yield ...

In the tech sector, investors should buy Meta (META) and Oracle (ORCL), Seaport Securities’ Ted Weisberg, the firm’s founder ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

This innovative project aims to enhance remote monitoring and enable early detection of IBD flares through digital biomarkers ...

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, describes how his company's ...

Trimtech Therapeutics has closed a seed funding round of $31m (£25m) to advance its pipeline of CNS penetrant therapeutics.

There is currently a strange paradox in the world of pharmaceutical shares, despite the sector’s well-known status as a safe haven. The performance gap between the S&P 500 index and US pharmaceutical ...